|Year : 2011 | Volume
| Issue : 3 | Page : 214-219
Clinicopathological pattern and management of retinoblastoma in Kano, Nigeria
Lawan Abdu1, Sani Malami2
1 Department of Ophthalmology, Faculty of Medicine, Bayero University Kano, Nigeria
2 Department of Pathology, Faculty of Medicine, Bayero University Kano, Nigeria
|Date of Web Publication||9-Sep-2011|
Department of Ophthalmology, Faculty of Medicine, Bayero University Kano
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background: The aim of the study is to evaluate the pattern of presentation and the mode of management of retinoblastoma seen in Aminu Kano Teaching Hospital, Kano from 2001 to 2005.
Materials and Methods: The clinic register was used to obtain the case folders of all children treated for retinoblastoma and this was used to obtain information on patient's age, sex, and clinical sign(s) at presentation such as orbital mass, leucocoria, proptosis, hyphaema without history of trauma, unexplained hypopyon, or uveitis. Also documented were X ray/B mode ultrasound scan findings, type of surgery performed, histological diagnosis, and adjuvant chemotherapy where applicable.
Results: Forty-two patients were reviewed, 15 males and 27 females (M: F = 1.0: 1.8). The age ranged between 2 and 6 years and the peak age of presentation was 3 years in 22 patients (52%). The tumor was unilateral in 40 patients (95%) and bilateral in 2 patients (5%). Most of the patients (46%) presented late with fungating orbital mass. Other signs include leucocoria 22%, proptosis 19%, hyphema 7%, Hypopyon 2%, squint 2%, and buphthalmos 2%. Thirty-one patients (74%) had exenteration and enucleation was performed in 11 patients (26%). The tumor was histologically confirmed in 41 patients (98%) and was poorly differentiated in 23 patients (55%), 1 patient (2%) had toxocara granuloma. Thirty-nine patients required adjuvant chemotherapy and only 2 received 6 (full) courses.
Conclusion: Retinoblastoma, a treatable tumor is characterized by late presentation as illustrated in our study. There is need to create public awareness and educate mothers on this tumor so that there is early diagnosis, appropriate referral, and prompt treatment. The goal is to increase number of children successfully cured of this disease in our environment.
| Abstract in French|| |
Arrière-plan: Le but de cette étude est d'évaluer le mode de présentation et le mode de gestion du rétinoblastome vu en Aminu Kano Teaching Hospital, Kano de 2001 à 2005.
Les patients et les méthodes: Le registre clinique a été utilisée pour obtenir les dossiers de cas de tous les enfants traités pour rétinoblastome et cela a été utilisé pour obtenir des informations sur l'âge du patient, le sexe et sign(s) clinique de présentation comme la masse orbitale, leucocoria, proptose, hyphaema sans antécédents de traumatisme, hypopion inexpliquée ou uvéite. Aussi documenté étaient des rayons X/conclusions de balayage de l'échographie de mode B, type de chirurgie effectué, le diagnostic histologique et chimiothérapie adjuvante le cas échéant.
Résultats: Quarante-deux patients ont été examinés, 15 mâles et 27 femelles (M: F = 1.0: 1,8). L'âge varie entre 2 et 6 ans et l'âge de pic de la présentation était 3 ans chez les 22 patients (52%). La tumeur était unilatérale dans 40 patients (95%) et bilatéraux dans 2 patients (5%). La plupart des patients (46%) a présenté fin avec fungating masse orbitale. D'autres signes comprennent leucocoria 22%, proptose 19%, Hyphéma 7%, hypopion 2%, squint 2% et buphthalmos % 2. Trente et un patients (74%) avaient exenteration et énucléation a été effectuée chez des 11 patients (26%). La tumeur a été confirmée histologiquement dans 41 patients (98%) et a été faiblement différenciée dans 23 patients (55%), 1 patient (2%) avait toxocara granulome. Trente-neuf patients requis une chimiothérapie adjuvante et seulement 2 a reçu 6 cours (complet).
Conclusion: Rétinoblastome, une tumeur traitable est caractérisé par la présentation tardive, tel qu'illustré dans notre étude. Il est nécessaire de sensibiliser le public et de sensibiliser les mères sur cette tumeur afin qu'il y a un diagnostic précoce, renvoi approprié et traitement rapide. L'objectif est d'augmenter le nombre d'enfants avec succès guéri de cette maladie dans notre environnement.
Mots clés: Gestion, présentation, rétinoblastome
Keywords: Management, presentation, retinoblastoma
|How to cite this article:|
Abdu L, Malami S. Clinicopathological pattern and management of retinoblastoma in Kano, Nigeria. Ann Afr Med 2011;10:214-9
| Introduction|| |
Retinoblastoma is the commonest ocular malignancy in childhood.  The incidence is 1 in 20000 live birth in developed countries  and is likely to be higher in our environment.  The average age of diagnosis is 18 months and in vast majority of cases it present within the first 3 years of life.  Retinoblastoma can be familial or sporadic. In familial retinoblastoma inheritance is autosomal dominant with 90-95% penetrance and 6% of these have a positive family history and tend to be of early onset and bilateral. They tend to have second non ocular tumors. Patients with familial retinoblastoma have a 50% risk of transmitting the disease to their children. The genetic defect that predisposes to familial retinoblastoma is located on long arm of chromosome 13 (13q14). Sporadic cases may be unilateral or, bilateral. Bilateral cases are considered to have germinal mutations and are said to be gene carriers. Ten to 15% of unilateral cases are as a result of germinal mutation and carry the gene as do bilateral cases. , This study highlights the pattern of presentation and clinicopathological features, and management of children with retinoblastoma over a 5 year period.
| Materials and Methods|| |
The clinic register was used to retrieve the case folders of all patients who presented with clinical features suggestive of retinoblastoma from 2001 to 2005. The following information was obtained; age, sex, tribe, and clinical details at presentation such as orbital mass, leucocoria, unexplained squint, hypopyon, endophthalmitis, uveitis in a child, or unexplained hyphema without history of trauma. The symptoms with duration at presentation were documented. Documented history of leucocoria was noted in patients who presented with orbital mass. Records of previous child with similar disease and history of application of traditional eye medicine were noted. All patients had basic eye examination. Vision was assessed in young children by fixation on light source, resistance to occlusion, and recognition of objects, picture charts, Landolts "C" chart or alphabet chart as the case may be. Basic eye examination included dilated fundoscopy of both eyes. Full clinical examination was conducted including examination of regional lymph nodes. Baseline investigations included full blood count (total and differential), hemoglobin genotype, urea and electrolytes, ECG, serum uric acid, orbital X-rays, and B scan was done for some of the patients. The patient's weight was measured and recorded. The modality of treatment was either enucleation or modified exenteration. Specimen was sent for histopathology. For those who had enucleation a request was made of the histological pattern at the point of optic nerve section. Patients with tumor at the point of optic nerve section, or, orbital metastasis were placed on adjuvant chemotherapy.
| Results|| |
There were 42 patients between the ages of 2 to 6 years with retinoblastoma. There were 15 males and 27 females (M: F = 1.0:1.8). The youngest age at presentation was 2 years and the oldest child was 6 years old. The age distribution of the patients is shown in [Figure 1] and [Figure 3] years was the commonest age at presentation in 22 cases (55%). Forty patients were of the Hausas/Fulani tribe. Two other patients (5%) were of Ebira and Gwari ethnic background. There were 40 patients (95%) with unilateral tumor and 2 patients (5%) had bilateral disease. Tumor presented in the right eye in 20 patients (48%) and left eye in 22 patients (52%). One of the 2 patients with bilateral tumors was a product of consanguineous marriage. The parents have other children and none had the tumor. Overall there was positive history of first cousin marriages in 5 patients. None of the families had another child with retinoblastoma. There was positive history of application of traditional eye medication in 14 patients (33%) at a certain unspecified stage of the disease. The remaining 28 patients (67%) denied applying such medications. The interval between onset of symptoms and seeking medical assistance ranged between 4 weeks and 6 months. All the patients had been taken to at least two other health facilities before reaching our hospital. Parents of 29 patients (69%) admitted they suspected a malady about 4 months before going to any health center. The common presenting signs are shown in [Figure 2] and [Figure 3] with fungating orbital mass being the most common sign seen in 19 patients (46%). Those 15 patients (36%) who presented with leucocoria, hyphema, or hypopyon were requested to do a B scan. Nine patients (21%) did the scan and six could not afford the cost. B scan findings include retinal masses extending into the vitreous and with associated calcification in eight of the nine patients scanned. Twenty nine patients (69%) had anterior-posterior and lateral skull X rays taken, which showed no obvious calcification. The main radiographic appearance was soft tissue shadow in patients with orbital mass. The surgical management was modified exenteration in 31 patients (74%) and enucleation in 11 patients (26%). All specimens were sent for histopathology report. Forty-one patients (98%) had histologically confirmed retinoblastoma and 1 patient (2%) had toxocara granuloma. Of the 11 enucleated eyes, the optic nerve was tumor free at the point of section in three patients (7%) and five patients had tumor infiltrations at point of optic nerve section. While in three remaining patients of this group, the distal end of the optic nerve was not identified in the sections. Out of 41 patients with retinoblastoma, the tumor was well differentiated in 10 patients (24%), and poorly differentiated in 23 patients (55%) as shown in [Figure 4]. Degree of differentiation was not specified in eight patients (19%). Of the 39 patients eligible for adjuvant chemotherapy, only 13 (33%) could be treated because of various reasons. The patients were to have six courses of the following agents: Vincristine 1.5 ng/m 2 , Cyclophosphamide 1000 ng/ m 2 , and Cytarabine 100 ng/m 2 . One patient with central nervous system involvement had intra thecal methotrexate. All the patients were placed on varied doses of Allupurinol daily during pulse therapy. Nine of the 13 patients had two courses before they missed subsequent appointment. Two patients requested for referral to another hospital closer to their home and only two had six courses of chemotherapy.
|Figure 2: 3 year old child with proptosis due to orbital extension of retinoblastoma in the right eye|
Click here to view
|Figure 4: Poorly differentiated retinoblastoma with area of calcifi cation (H&E x 100)|
Click here to view
| Discussion|| |
Reliable population data on the incidence of retinoblastoma in our environment is not available, but hospital based series indicates that it is the commonest childhood ocular malignancy accounting for 60% of all childhood eye cancers.  It is claimed that retinoblastoma has a prenatal origin as occurrence is soon after birth  and there is a report of prenatal diagnosis of retinoblastoma  About half of our patients presented at the age of 3 years compared to 89% that presented before the age of 3 years in other parts of the world.  Retinoblastoma is also said to be commoner in African than Caucasian children,  and is characterized by late presentation in Africa.  The oldest patient in our study was 6 years old though there is a report of retinoblastoma in a 23 year old male,  and in the second (seeing eye) of a 27 year- old who had chemotherapy and Argon laser photocoagulation of the contra lateral eye in childhood indicating its rare occurrence in adults.  In our study, retinoblastoma was commoner in girls than boys though there is no sex predilection. Most of the patients in our study were of Hausa/Fulani tribe and this is probably due to the location of the hospital. There are intermarriages between and amongst the two groups such that many Hausas have mixed background. It is possible that unidentified environmental factors may play a role in rampant occurrence of the tumor in this group. The familial type of retinoblastoma is transmitted by autosomal dominant trait and consanguinity, a common practice among this group may not fully explain the frequent occurrence of the disease. None of the parents of the patients studied had a previous child with retinoblastoma. The risk of transmitting familial type of retinoblastoma is 50%.  Most of the patients presented months after symptoms were noticed, unlike the study in Ibadan where patients presented within one month of appearance of symptoms though only 5 out of 26 patients received full treatment. Many patients defaulted because of fear of enucleation and problems of treatment include financial constraints regarding investigations and medications, and availability of chemotherapy,  similar to the experience we had in our hospital. These factors contribute to late onset of treatment even for patients who presents with early disease. Socioeconomic and cultural reasons contribute to children presenting late with advanced disease in low income countries. The commonest mode of presentation was fungating orbital mass similar to the pattern in Nepal district of India where 40% presented with orbital mass.  Leucocoria was the second commonest presentation in one fifth of patients compared to 60% in other reports, another indication that patients present late.  We noticed that more than half of the parents noticed leucocoria at the early stage of the disease, but only a third had leucocoria at the time of presentation. With proper health education more parents (mothers) can detect this anomaly and report to the hospital early. Ultrasound B scan was requested for patients with leucocoria, not all the patients who needed to do the scan could afford the cost. B scan was helpful in making diagnosis particularly where the retinal view was obscured by secondary cataracts or, uveitis. High resolution B scan is helpful in early detection of retinoblastoma, particularly those in the anterior segment.  Our study showed that B scan is more useful in detection of intra ocular calcification than orbital X-rays, which showed no calcification in all the patients tested. Ocular ultrasound is useful in making a diagnosis and shows calcification in 91.3% in some reports.  Application of traditional eye medicine can worsen the symptoms complex leading to corneal melting or introducing infection. The goal of management is patient's survival and globe preservation and treatment is tailored to each individual case. Various mode of management includes chemoreduction, focal therapy, laser photocoagulation, external beam irradiation, and crayotherapy. Radical treatment that results in enucleation is unnecessary in centers with better facilities. The international classification of retinoblastoma ICRB that grouped the tumor based on size and extent showed that most of our patients are in group E and present with extensive disease. This explain the reason for radical surgery in most cases as other alternatives such as chemotherapy with sub conjunctival Carboplatin proved to be successful elsewhere are unavailable.  Features of retinoblastoma invasion beyond lamina cribrosa in the optic nerve, choroid, sclera, orbit, or anterior chamber is an indication for chemotherapy.  Chemoreduction is a means of reducing tumor size with a view to apply more focal treatment,  and is an important step in the management of this disease.  Because the patients presented late, modified exenteration, which involved removal of all the orbital contents excluding orbital periosteum was the surgical operation performed in most of the patients, followed by enucleation. In developed countries, enucleation is reserved for cases with advanced disease with no hope for useful vision or when there is concern of invasion of neighboring structures.  Histologically, confirmed retinoblastoma was the commonest cause of removal of the eye in 48% of patients seen in our hospital.  Intra ocular tumor was the cause of removing the eye in 26% of children in Jos, Nigeria.  Despite the poor cosmetic effect, enucleation was the only treatment of choice in Lagos  for those without orbital extension. In Ibadan, Nigeria 37 patients (84%) had enucleation and 7 patients (16%) exenteration perhaps because the patients presented early.  Small tumors less than 3 mm in size in the posterior segment can be treated with focal laser photocoagulation. The aim is to apply two rows of laser burn around the tumor avoiding direct treatment as this can lead to vitreous seeding.  Crayotherapy is useful in treatment of small peripheral retinoblastoma.  External beam irradiation is known to offer good results in patients with advanced disease  as reported in our study though it is associated with risk of secondary tumors.  The clinical diagnosis of retinoblastoma correlated with the histological diagnosis in 98% of patients. Effectively, only a small number of patients without histological evidence of tumor invasion were cured. The tumor was poorly differentiated in more than half of the patients. Poorly differentiated tumors are commoner accounting for 58% in India  and 97% in Uganda.  Invasion of neighboring structures was commoner with undifferentiated retinoblastoma.  However, poorly differentiated retinoblastoma tend to be more radio sensitive.  We have no facilities for radiotherapy or crayotherapy in our hospital. In one patient the histology showed toxocara granuloma instead of the tumor diagnosed clinically. Intra ocular fine needle aspiration (FNAB) cytology under general anesthesia can be a viable option in making a diagnosis of retinoblastoma in selected cases.  Ratios of aqueous to plasma lactate dehydrogenase enzyme is high in eyes with retinoblastoma.  The technique is minimally invasive. Visualization of central retinal vessels with enhancement (contrast) on computed tomography (CT) scan indicates that the optic nerve is tumor free,  this is useful in making decision on mode of treatment. A patient on chemotherapy had central nervous system metastases and did not do well even with administration of intra-thecal methotrexate. Favorable response had been reported with methotrexate in other centers.  Neuroblastic intra cranial malignancy manifesting as intra cranial tumor is more associated with hereditary retinoblastoma.  Few of the patients who needed chemotherapy had a full course of the treatment. Many factors contributed to this, such as distance from the hospital, cost of multiple hospital admission, and cost of blood transfusion. Poverty is pivotal, as it cost about $45 (United States) per course of chemotherapy. In view of these factors, it is possible that many of the patients that were lost to follow up had eventually passed away without ever receiving full course of treatment. Decades ago mortality from retinoblastoma in Nigeria was 100%.  There is need to improve on early detection so as not to revert to the days of high mortality from this curable tumor. We are far away from 92% five year survival in Caucasian children.  Other modalities of treatment aimed at preserving vision such as chemo reduction, Argon laser photocoagulation, radio active plague therapy are better imagined in our environment. In our part of the world, the battle is to save lives first and then sight. It is therefore not surprising that the idea of use of anti cyclooxygenase 2 in years to come to treat retinoblastoma  may still be far from the reach of most of our patients. Our study indicates the limitations in access to facilities were children with retinoblastoma can be assessed early and treated promptly. There is cost attached to treatment and most of the families affected are of poor socioeconomic background. There is need to raise public awareness of this tumor and encourage funding of treatment by government and other support groups so that affected children are successfully cured.
| References|| |
|1.||Pam V. Ocular tumors in childhood. Nig J Surg Res 2001;3:1-5. |
|2.||Kansky JJ. Clinical ophthalmology. London: Butterworth- Heinemann; 1994. p. 222-5. |
|3.||Klauss V, Chana HS, Khan FA. Retinoblastoma in developing countries. Fortschr Ophthalmol 1983;80:87-90. |
|4.||Shields CL, Shields JA. Genetics of retinoblastoma. In: Tasman WS, Jaega E, editors. Duane's foundation of clinical ophthalmology. 3rd ed. Philadelphia, Pa: Lippincott Williams Wilkins; 2002. |
|5.||Abiose A, Adido J, Agarwal SC. Childhood malignancies of the eye and orbit in northern Nigeria. Cancer 1985;55:2889-93. |
|6.||Jensen RD, Miller RW. Retinoblastoma: Epidemiologic characteristics. New Eng J Med 1971;285:307-11. |
|7.||Salim A, Wiknjosastro GH, Danukusumo D, Barnas B, Zalud I. Fetal retinoblastoma. J Ultrasound Med 1998;17:712-20. |
|8.||Yanoff M, Duker JS. Ophthalmology. St. Louis: CV Mosby; 1999. p. 68. |
|9.||Junaid TA, Babalola BA. Ibadan cancer registry 1960-1984, In International Incidence of Childhood cancers. Lyon: IARC Scientific Publication No. 87; p. 37-41. |
|10.||Goldberg L. The rising incidence of retinoblastoma in blacks. S Afr Med J 1977;51:368. |
|11.||Pam VA, Mohammed I, Olali CA. Retinoblastoma in an adult: A case report. West Afr J Med 1998;17:280-3. |
|12.||de Jong PT, Mooy CM, Stoter G, Eijkenboom WM, Luyten GP. Late onset retinoblastoma in a well functioning eye. Ophthalmology 2006;113:1040-4. |
|13.||Bakibele CO, Ayede AI, Asaolu OO, Brown BJ. Retinoblastoma: The Challenges of management in Ibadan, Nigeria. J Pediatr Hematol Oncol 2009;31:552-5. |
|14.||Badthu B, Sah, SP, Thakur SK, Dulal S, Kumar S, Sood A, et al. Clinical presentation of retinoblastoma in Eastern Nepal. Clin Experiment Ophthalmol 2005;33:386-9. |
|15.||Shields CL, Shields JA, Shah P. Retinoblastoma in older children. Ophthalmology 1991;98:395-9. |
|16.||Finger FT, Meskin SW, Wisnicki HJ, Albekioni Z, Schneider S. High frequency ultrasound in anterior segment retinoblastoma. Am J ophthalmol 2004;137:944-6. |
|17.||Roth DB, Scott IU, Murray TG, Kaiser PK, Feuer WJ, Hughes JR, et al. Echography of retinoblastoma: histologic correlation and serial evaluation after globe conserving radiotherapy or chemotherapy. J Pediatr Ophthalmol Strabismus 2002;38:136-43. |
|18.||Abramson DH, Frank CM, Dunkel IJ. A phase I/II study of sub conjunctival carboplatin for intra ocular retinoblastoma. Ophthalmology 1999;106:1947-50. |
|19.||Honavar SG, Singh AD, Shields CL, Meadows AT, Demirci H, Cater J, et al. Post enucleation adjuvant therapy in high risk retinoblastoma. Arch Ophthalmol 2002;120:923-31. |
|20.||Shields CL, Shields JA. Editorial: Chemotherapy for retinoblastoma. Arch Ophthalmol 2002;38:377-8. |
|21.||Ferries FL 3rd, Chew EY. A new era for treatment of retinoblastoma. Arch Ophthalmol 1996;114:1412. |
|22.||Shields JA, Shields CL, Sivalingam V. Decreasing frequency of enucleation in patients with retinoblastoma. Am J Ophthalmol 1989;108:185-8. |
|23.||Abdu L, Mohammed AZ. Indications for surgical removal of the eye in Kano- Nigeria. A five year review. Niger J Basic Clin Sci 2008;5:1-4. |
|24.||Mpyet C, Ramyil AV. Indications for surgical removal of the eye in children; a five year review. Afr J Paediatr Surg 2005;2:8-11. |
|25.||Majekodunmi S. Causes of enucleation of the eye at Lagos University Teaching Hospital. A study of 101 eyes. West Afr J Med 1989;8:288-91. |
|26.||Ajaiyeoba IA, Akang EEV, Campball OB, Olurin IO, Aghadiuno PU. Retinoblastoma in Ibadan treatment and prognosis. West Afr J Med 2003;2:223-7. |
|27.||Shields CL, Shields JA, Kiratli H, De Potter PV. Treatment of retinoblastoma with indirect ophthalmoscope laser photocoagulation. J Pediatr Ophthalmol Strabismus 1995;32:317-22. |
|28.||Shields JA, Parsons H, Shields CL, Giblin ME. The role of crayotherapy in the management of retinoblastoma. Am J Ophthalmol 1989;108:260-4. |
|29.||Shields CL, Shields JA. Diagnosis and management of retinoblastoma. Cancer Control 2004;11:317-27. |
|30.||Roarty JD, McLean IW, Zimmerman LE. Incidence of second neoplasm's in patients with retinoblastoma. Ophthalmology 1988;95:1583-7. |
|31.||Biswas J, Das D, Krishnakumar S, Shanmugam MP. Histologic analysis of 232 eyes with retinoblastoma conducted in an Indian tertiary care ophthalmic center. J Pediatr Ophthalmol Strabismus 2003;40:265-7. |
|32.||Mukhtar AU, Kagame K. Pathological study of retinoblastoma in Mbarara, Uganda. Cent Afr J Med 2000;46:13-6. |
|33.||Bosun I, Simionescu C. The extension of retinoblastoma into neighboring structures. Oftalmologia 1998;44:47-52. |
|34.||Hope Stone HF. Radiotherapy in clinical practice. London: Butterworth 1986. p. 254-5. |
|35.||Sens S, Singha U, Kumar H, Ghose S, Sarkar T, Bajaj MS. Diagnostic intraocular fine needle aspiration biopsy- An experience in three cases of retinoblastoma. Diagn Cytopathol 1999;21:331-4. |
|36.||Jacquemin C, Karcioglu ZA. Detection of optic nerve involvement in retinoblastoma with enhanced computed tomography. Eye (Lond) 1998;12:179-83. |
|37.||Malik M, Prabhakar R, Sharma DN, Rath GK. Retinoblastoma with spinal fluid metastases treated with orbital and craniospinal irradiation using IMRT. Technol Cancer Res Treat 2006;5:497-501. |
|38.||Kivelä T. Trilateral retinoblastoma: A Meta analysis of hereditary retinoblastoma associated with primary ectopic intra cranial retinoblastoma. J Clin Oncol 1999;17:1829-37. |
|39.||Kodilinye HC. Retinoblastoma in Nigeria: Problems of treatment. Am J Ophthalmol 1967;63:469-81. |
|40.||Sanders BM, Draper GJ, Kinston JE. Retinoblastoma in Great Britain 1969-80: Incidence, treatment and survival. Br J Ophthalmol 1988;73:576-83. |
|41.||Souza Filho JP, Martins MC, Correa ZM, Odashiro AN, Antecka E, Coutinho AB, et al. The expression of cyclooxygenase 2 in retinoblastoma: primary enucleation eyes and enucleation after conservative treatment. Am J ophthalmol 2006;142: 625-31. |
[Figure 1], [Figure 2], [Figure 3], [Figure 4]
|This article has been cited by|
||Clinical Presentations and Outcomes of Retinoblastoma Patients in relation to the Advent of New Multimodal Treatments: A 12-Year Report from Single Tertiary Referral Institute in Thailand
| ||Duangnate Rojanaporn, Taweevat Attaseth, Wimwipa Dieosuthichat, Kitikul Leelawongs, Samart Pakakasama, Usanarat Anurathapan, Ekachat Chanthanaphak, Sirintara Singhara Na Ayudhaya, Rangsima Aroonroch, Suradej Hongeng |
| ||Journal of Ophthalmology. 2020; 2020: 1 |
|[Pubmed] | [DOI]|
||Integrating stages of change models to cast new vision on interventions to improve global retinoblastoma and childhood cancer outcomes
| ||Meaghann S Weaver,Christina L Heminger,Catherine G Lam |
| ||BMC Public Health. 2014; 14(1): 944 |
|[Pubmed] | [DOI]|
||Pediatric case series in an ophthalmic camp in Turkana (Kenya)
| ||S. Noval,L. Cabrejas,E. Jarrín,M. Ruiz-Guerrero,E. Ciancas |
| ||Archivos de la Sociedad Española de Oftalmología (English Edition). 2014; |
|[Pubmed] | [DOI]|
||Serie pediátrica en una campaña oftalmológica en Turkana (Kenia)
| ||S. Noval,L. Cabrejas,E. Jarrín,M. Ruiz-Guerrero,E. Ciancas |
| ||Archivos de la Sociedad Española de Oftalmología. 2013; |
|[Pubmed] | [DOI]|
||Association of retinoblastoma with clinical and histopathological risk factors
| ||Asad Aslam Khan,Mulazim Hussain Bukhari,Riffat Mehboob |
| ||Natural Science. 2013; 05(04): 437 |
|[Pubmed] | [DOI]|